CSF2 and neoplasm: Utilizing tumor-specific promoters such as CXCR4-promoter allows for tumor-specific transgene expression, driving high expression of therapeutic genes like GM-CSF and B7-1, thereby enhancing immune cell activation and infiltration into tumors [85,113].